Home Tools
Log in
Cart

Teneligliptin

Catalog No. T37522   CAS 760937-92-6

Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Teneligliptin Chemical Structure
Teneligliptin, CAS 760937-92-6
Pack Size Availability Price/USD Quantity
5 mg 5 days $ 30.00
10 mg 5 days $ 44.00
1 mL * 10 mM (in DMSO) 5 days $ 43.00
Bulk Inquiry
Get quote
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.
Targets&IC50 DPP4:1 nM (IC50)
In vitro Teneligliptin (MP-513) demonstrates concentration-dependent inhibition of DPP-4 enzymes across various contexts, with IC50 values of 0.889 nM for rhDPP-4, 1.75 nM for human plasma, and 1.35 nM for rat plasma. Enzyme inhibition kinetics, analyzed using Gly-Pro-MCA substrate and rhDPP-4, show Teneligliptin acts via a substrate-competitive mechanism. This is supported by residual sum of squares analyses, yielding 0.162 for competitive and 0.192 for non-competitive models, alongside calculated Ki, Km, and Vmax values of 0.406 nM, 24 μM, and 6.06 nmol/min, respectively. Furthermore, Teneligliptin effectively protects GLP-1(7-36)amide from degradation, evidenced by an IC50 of 2.92 nM.
In vivo Oral administration of Teneligliptin (MP-513) to Wistar rats significantly inhibits plasma DPP-4 activity, achieving an ED50 of 0.41 mg/kg and maintaining this inhibition for 24 hours post-dose. When administered to Zucker fatty rats, Teneligliptin at doses of 0.1 mg/kg or higher enhances plasmaglucagon-like peptide-1 and insulin levels, curtails glucose levels during oral carbohydrate challenges up to 12 hours after a 1 mg/kg dose, and reduces triglyceride and free fatty acid levels after oral fat challenges. Continuous dosing over two weeks similarly decreases blood glucose, triglycerides, and free fatty acids under non-fasting conditions. Compared to Sitagliptin and Vildagliptin, with ED50 values of 27.3 and 12.8 mg/kg respectively, Teneligliptin shows a markedly higher potency in dose-dependent plasma DPP-4 inhibition. Additionally, Teneligliptin improves liver histopathology and reduces intrahepatic triglyceride levels in NAFLD model mice by downregulating genes involved in hepatic lipogenesis through AMPK activation.
Kinase Assay DPP-4 inhibition assay is carried out using either 5 ng purified recombinant human DPP-4 (rhDPP-4), human plasma (20-fold diluted with assay buffer; phosphate-buffered saline (PBS) containing 0.003% Brij-35 solution), or rat plasma (10-fold diluted with assay buffer) Gly-Pro-MCA as a chromogenic substrate as described previously with slight modifications. DPP-4 inhibitors (Teneligliptin, Sitagliptin, and Vildagliptin) are diluted with assay buffer at several concentrations. Twenty microliters of inhibitor solution, 20 μL of the enzyme source, and 20 μL of Gly-Pro-MCA (final concentration, 25 μM) are mixed with 140 μL or 160 μL of assay buffer to initiate the enzyme reaction. After 20 min (rhDPP-4) or 1 h (plasma) at 37°C, the fluorescence intensity of 7-amino-4-methyl-coumarin (AMC) generated from Gly-Pro-MCA is measured using an automated microplate reader at 360 nm excitation and 465 nm emission. The fluorescence intensity of AMC corresponded to DPP-4 activity[1].
Molecular Weight 426.58
Formula C22H30N6OS
CAS No. 760937-92-6

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 33.33 mg/mL (78.13 mM)

TargetMolReferences and Literature

1. Fukuda-Tsuru S, et al. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol. 2012 Dec 5;696(1-3):194-202. 2. Ideta T, et al. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice. Int J Mol Sci. 2015 Dec 8;16(12):29207-18.

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Teneligliptin 760937-92-6 inhibitor inhibit

 

TargetMol